Overview

Topiramate in the Treatment of Pathological Gambling

Status:
Terminated
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy of topiramate in the treatment of pathological gambling. Pathological gambling (PG) is a debilitating disorder, generally leading to severe personal, familial, financial, social, and occupational impairments. In PG, the patient experiences a progressive inability to resist impulses to gamble, and gambling significantly disrupt the patient's functioning in the personal, familial, and/or vocational spheres. Topiramate has shown preliminary evidence of efficacy in some impulse control disorders.
Phase:
Phase 3
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborator:
Ortho-McNeil, Inc.
Treatments:
Topiramate